BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17197803)

  • 1. In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype.
    Geldmacher C; Currier JR; Gerhardt M; Haule A; Maboko L; Birx D; Gray C; Meyerhans A; Cox J; Hoelscher M
    AIDS; 2007 Jan; 21(2):135-43. PubMed ID: 17197803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific immune responses to human immunodeficiency virus type 1 Gag, Tat, Rev and Nef proteins].
    Zhai S; Kang WZ; Yu X; Wang SY; Walker BD; Altfeld M; Sun YT
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):175-9. PubMed ID: 15766402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.
    Geels MJ; Dubey SA; Anderson K; Baan E; Bakker M; Pollakis G; Paxton WA; Shiver JW; Goudsmit J
    J Virol; 2005 Sep; 79(17):11247-58. PubMed ID: 16103177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher cross-subtype IFN-γ ELISpot responses to Gag and Nef peptides in Brazilian HIV-1 subtype B- and F1- than in C-infected subjects.
    Côrtes FH; Bello G; Vorsatz C; Pilotto JH; Guimarães ML; Grinsztejn B; Veloso VG; Pinto AR; Morgado MG
    Vaccine; 2013 Feb; 31(7):1106-12. PubMed ID: 23261042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles.
    Gudmundsdotter L; Bernasconi D; Hejdeman B; Sandstrom E; Alaeus A; Lidman K; Ensoli B; Wahren B; Buttò S
    Vaccine; 2008 Sep; 26(40):5182-7. PubMed ID: 18479789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants.
    Turk G; Gherardi MM; Laufer N; Saracco M; Luzzi R; Cox JH; Cahn P; Salomon H
    J Virol; 2008 Mar; 82(6):2853-66. PubMed ID: 18184702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Nef-specific CD8 T-cell responses and disease progression in HIV-1 subtype B infection.
    Jiao Y; Li TS; Xie J; Han Y; Qiu ZF; Zuo LY; Mourez T; Wang AX
    Chin Med J (Engl); 2006 Oct; 119(19):1609-15. PubMed ID: 17042973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
    Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
    Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of gag-specific IFN-gamma secretion responses in HIV-1 B/C recombinant infectors].
    Liu HW; Hong KX; Yuan Y; Liu CH; Chen JP; Ruan YH; Wang Z; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):358-60. PubMed ID: 22338224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: impact of age.
    Buseyne F; Scott-Algara D; Corre B; Porrot F; Monchatre E; Bellal N; Burgard M; Rouzioux C; Blanche S; Rivière Y
    Virology; 2006 Oct; 354(2):271-9. PubMed ID: 16904156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.
    Megede JZ; Otten GR; Doe B; Liu H; Srivastava R; Greer C; Legg H; Tang T; Polo JM; Donnelly JJ; Ulmer JB; Barnett SW
    Vaccine; 2006 Apr; 24(15):2755-63. PubMed ID: 16460840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally.
    Makedonas G; Bruneau J; Alary M; Tsoukas CM; Lowndes CM; Lamothe F; Bernard NF
    AIDS; 2005 Feb; 19(3):251-9. PubMed ID: 15718835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of HIV-1 CRF02_AG-specific T cell responses indicates the dominance of a p24gag epitope in blood donors in Abidjan, Cote d'Ivoire.
    Chahroudi A; Sawadogo S; Ellenberger D; Pieniazek D; Borget-Alloue MY; Aidoo M; Koblavi-Deme S; Fernandez-Vina M; Maurice C; Chorba T; Nkengasong JN; McNicholl JM
    J Infect Dis; 2005 Oct; 192(8):1417-21. PubMed ID: 16170760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunodominance in CD8+ T cell responses to HIV-1 synthesized epitopes].
    Tang YB; Tang XP; Jin X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):217-9. PubMed ID: 17971925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents.
    Coplan PM; Gupta SB; Dubey SA; Pitisuttithum P; Nikas A; Mbewe B; Vardas E; Schechter M; Kallas EG; Freed DC; Fu TM; Mast CT; Puthavathana P; Kublin J; Brown Collins K; Chisi J; Pendame R; Thaler SJ; Gray G; Mcintyre J; Straus WL; Condra JH; Mehrotra DV; Guess HA; Emini EA; Shiver JW
    J Infect Dis; 2005 May; 191(9):1427-34. PubMed ID: 15809900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: implications for vaccine development.
    Tongo M; Zembe L; Ebong E; Roux S; Bekker LG; Williamson C; Mpoudi-Ngole E; Burgers WA
    Vaccine; 2014 Apr; 32(20):2328-36. PubMed ID: 24598726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides.
    Bansal A; Gough E; Sabbaj S; Ritter D; Yusim K; Sfakianos G; Aldrovandi G; Kaslow RA; Wilson CM; Mulligan MJ; Kilby JM; Goepfert PA
    AIDS; 2005 Feb; 19(3):241-50. PubMed ID: 15718834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
    Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.